Adaptimmune Therapeutics plc (ADAPY)
Engineers immune cells to attack and destroy cancer tumors in patients
$0.03+0.10%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-58.7%
The outlook
ADAPY is trading near its 52-week lows, sitting just 12% above the year's bottom. The stock shows mixed positioning relative to its moving averages, and analyst sentiment currently leans bearish. At roughly $0.033, the price reflects the cautious market view on the company.
What’s behind the score
Price trendMixed vs its moving averages
52-week range12% of the way from its 52-week low to high
Market cap
$8.7M
52-wk high
$0.28
52-wk low
$0.00
50-day avg
$0.03
200-day avg
$0.04
Trailing P/E
—